Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Forest M White

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Nature|June 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn, et al.
Neuro-Oncology|September 26, 2015
CNS Anticancer Drug Discovery and Development Conference White PaperVictor A Levin, Peter J Tonge, James M Gallo, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Nature|June 4, 2013
The bromodomain protein Brd4 insulates chromatin from DNA damage signallingScott R Floyd, Michael E Pacold, Qiuying Huang, et al.
NAR Cancer|June 25, 2026
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Neuro-Oncology|August 12, 2021
Multimodal platform for assessing drug distribution and response in clinical trialsBegoña G C Lopez, Ishwar N Kohale, Ziming Du, et al.
Nature Communications|November 23, 2018
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastomaElizabeth C Randall, Kristina B Emdal, Janice K Laramy, et al.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Nature|June 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn, et al.
Neuro-Oncology|September 26, 2015
CNS Anticancer Drug Discovery and Development Conference White PaperVictor A Levin, Peter J Tonge, James M Gallo, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Frontiers in Immunology|January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor modelJ Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Nature|June 4, 2013
The bromodomain protein Brd4 insulates chromatin from DNA damage signallingScott R Floyd, Michael E Pacold, Qiuying Huang, et al.
NAR Cancer|June 25, 2026
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancerLee J Pribyl, Jennifer E Kay, Joshua J Corrigan, et al.
Neuro-Oncology|August 12, 2021
Multimodal platform for assessing drug distribution and response in clinical trialsBegoña G C Lopez, Ishwar N Kohale, Ziming Du, et al.
Nature Communications|November 23, 2018
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastomaElizabeth C Randall, Kristina B Emdal, Janice K Laramy, et al.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Pageof 17